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Vascular cell biology is an area of research with great biomedical relevance. Vascular dysfunction is involved in major diseases such
as atherosclerosis, diabetes, and cancer. However, when studying vascular cell biology in the laboratory, it is diﬃcult to mimic
the dynamic, three-dimensional microenvironment that is found in vivo. Microﬂuidic technology oﬀers unique possibilities to
overcome this diﬃculty. In this review, an overview of the recent applications of microﬂuidic technology in the ﬁeld of vascular
biological research will be given. Examples of how microﬂuidics can be used to generate shear stresses, growth factor gradients,
cocultures,andmigrationassayswillbeprovided.Theuseofmicroﬂuidicdevicesinstudyingthree-dimensionalmodelsofvascular
tissue will be discussed. It is concluded that microﬂuidic technology oﬀers great possibilities to systematically study vascular cell
biology with setups that more closely mimic the in vivo situation than those that are generated with conventional methods.
Copyright © 2009 A. D. van der Meer et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Vascularscienceisanactiveareaofresearch.Scientistsworld-
wide are trying to unravel the mechanisms that determine
vascular function and dysfunction. Important objects of
study in this ﬁeld of research include the maintenance of
vascular tone [1], regulation of inﬂammation [2], sprouting
of new blood vessels [3], regulation of cell survival [4],
and the diﬀerentiation of stem cells into vascular tissue
[5]. Vascular science is a ﬁeld with a strong translational
focus, combining results from fundamental molecular and
cell biology with in vitro models of blood vessels and in
vivo tests to develop insight in vascular physiology and
treatment of disease. Vascular dysfunction is an important
factor in major diseases like atherosclerosis [6], cancer [7],
anddiabetes[8].Thebasisforunderstandingthefunctioning
of blood vessels lies in understanding its building blocks,
the vascular cells. Therefore, a lot of research is focused
on how endothelial cells or smooth muscle cells react
to relevant biological, chemical, or physical cues in vitro.
U s u a l l y ,t h i sw o r ki sc a r r i e do u tb yu s i n gc o n v e n t i o n a l
methods, culturing cells of animal or human origin in
wells-plates, subjecting them to the aforementioned stimuli,
and analyzing the outcome by biological or biochemical
techniques.However,invivodynamicconditionsarepresent:
vascular endothelial cells are constantly subjected to shear
stress caused by the ﬂowing blood [9], while smooth muscle
cells are stretched because of distension of the blood vessel
during the cardiac cycle [10]. Moreover, vascular cells are
embedded in a three-dimensional environment consisting
of an elastic extracellular matrix [11], other cells [12], and
ﬂowing blood, with its platelets [13], red blood cells [14],
and leukocytes [15]( Figure 1). Both the three-dimensional
environmentand thedynamic mechanicalchangeswitheach
cardiac cycle are very important factors in vascular cell
functioning. It is advantageous to design laboratory setups
that allow researchers to include these factorsand control the
relevant parameters. The main challenge when building such
setups is that they should still be easy to assemble, handle,
and combine with conventional analysis techniques.
In the recent years, the ﬁeld of microﬂuidic technol-
ogy has gained much scientiﬁc interest among biologists,
biochemists, and biophysicists (Figure 2). We feel that
microﬂuidic technology holds great promise to overcome2 Journal of Biomedicine and Biotechnology
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Figure 1: Schematic overview of a blood vessel and the endothelial cell microenvironment. The inner wall of a blood vessel (left) consists of
a layer of endothelial cells that are embedded in a three-dimensional microenvironment (right). This environment consists of cell biological,
biochemical, and physical stimuli, such as red and white blood cells, signaling molecules, and shear stress, respectively. Mimicking this
complex microenvironment in vitro is a major challenge in vascular research.
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Figure 2: Graph of the amount of papers containing the keyword
“microﬂuidic” that were published per year as determined with
Google Scholar. A more than 30-fold increase in the yearly number
of scientiﬁc publications with this particular keyword can be
observed in the decade between 1995 and 2005.
the challenge of performing in vitro experiments with
more physiologically realistic setups that are still simple
enoughtobeusedineverydaylaboratorypractice.Moreover,
microﬂuidictechnologyallowsforincreasingscaleandparal-
lelizationofcurrentresearch,leadingtomorecomprehensive
insights into cell and tissue physiology. The advantages of
microﬂuidic technology for cell culture in general have been
reviewed elsewhere [16, 17]. In this review, we will focus
speciﬁcally on the application of microﬂuidic devices in
vascular cell biology research.
2. MicroﬂuidicTechnology
2.1. Fabrication. Microﬂuidic technology deals with the
design, fabrication, and application of devices for manipu-
lation of ﬂuids on the micrometer scale. Typically, the sizes
of features in these devices range from several micrometers
to a few hundred micrometers. The amounts of ﬂuid that are
manipulated inside these devices are typically in the picoliter
to nanoliter range. Microﬂuidic devices can be fabricated
using metal, glass, or polymer materials. Most devices that
are used in combination with cell biological research are
made of glass or the silicone rubber polydimethylsiloxane
(PDMS), because these materials are cheap, biocompatible,
and transparent.
Because all microﬂuidic studies that are discussed in this
review use microﬂuidic devices of PDMS (sometimes com-
binedwithglasscomponents),theprocessofproducingthese
devices will be described shortly (see also Figure 3). PDMS
devices are produced by soft lithography replica molding
[18], which means that the devices are elastic replicas of
as t i ﬀ, reusable mold. The process starts by producing the
stiﬀ mold with the desired structures. The mold is usually
made of silicon with micrometer-size structures produced
either by plasma-etching of the silicon plate or by building
ontopoftheplatewiththeepoxy-based,photo-crosslinkable
polymer SU-8. A mixture of PDMS oligomers is poured on
top of this mold, allowed to solidify by crosslinking, and
then peeled oﬀ from the mold. In order to create sealed
channels, the surface of the PDMS replica is activated with
oxygen plasma and bound to a PDMS or glass surface.
Holescanbe puncturedto reachthe closedchannelstructure
and tubing can be connected to manipulate ﬂuid inside the
channels. The silicon master-molds need to be produced inJournal of Biomedicine and Biotechnology 3
Silicon
master mold
(a)
PDMS
casting
(b)
PDMS binding
on surface
(c)
Microﬂuidic
device
(d)
Figure 3: Schematic overview of the fabrication of PDMS chips.
(a) The process starts by fabricating a silicon master mold—
with typical dimensions of 10 centimeter in diameter and 0.5
millimeter thickness—with microﬂuidic structures on top. (b) A
viscous mixture of PDMS oligomers and crosslinker is poured on
top of the mold and allowed to form a ﬂexible, crosslinked network.
(c) The slab of PDMS is peeled oﬀ of the mold and bound to a
glass or PDMS surface to produce closed microﬂuidic channels. (d)
The microﬂuidic device is ready to be used. Prior to binding to the
surface, holes can be punched in the slab of PDMS to reach the
resulting microﬂuidic channel.
a clean room, but replica molding can be performed under
standard laboratory conditions. Once the master-mold has
been created, producing new microﬂuidic devices by this
method takes only a few hours. Because the materials are
cheap, microﬂuidic devices can be discarded after every
experiment.
2.2. Cells and Microﬂuidic Technology. Generally speaking,
PDMS microﬂuidic devices oﬀer a number of distinct
advantages over conventional techniques for cell culturing,
manipulation, and analysis. The main feature of microﬂuidic
devicesthatmakesthemsuitableforuseincellbiologyisthat
they are smaller than conventional setups (for an impression
ofthesizeofamicroﬂuidicchannel,seeFigure 4(a)).Because
of this small size, only limited amounts of cells, media, and
reagents are needed. This leads to a number of signiﬁcant
beneﬁts. First of all, if experiments are to be conducted
with rare primary cell material or expensive drugs, it is
quite advantageous to use only small quantities of these
valuable materials. Secondly, if cultures are to be maintained
under conditions of constant ﬂuid ﬂow, small sizes are
a considerable advantage. In conventional bioreactors, cell
culture medium is usually collected and re-used after it has
passedthroughthecellculturechamber.Themediumisthen
completely replaced every few days. In microﬂuidic devices,
a constant ﬂux of fresh medium can be used, because the
volumes involved are orders of magnitude smaller. The third
beneﬁt is that the small, planar and transparent microﬂuidic
setups are easily combined with bright ﬁeld and ﬂuorescence
microscopy or spectroscopy, because they ﬁt easily on stages
of conventional microscopes. This facilitates monitoring
cell behavior for long periods and with high magniﬁcation
during the experiment.
It is important to realize that cells that are cultured
inside microﬂuidic devices need to be subjected to a constant
ﬂux of fresh medium. When the small volumes in the cell-
containing devices would be left under static conditions,
nutrients would be depleted quickly, whereas waste products
would increase to undesirable concentrations. The fact
that constant refreshment of medium is needed may seem
cumbersome at ﬁrst glance. However, under physiological
conditions, all cell types need a ﬂux of nutrients and waste
products. The ﬂow conditions in microﬂuidic devices mimic
this process more closely than in vitro culturing in wells
plates [19].
Because of the small dimensions of microﬂuidic chan-
nels, ﬂuid ﬂow is fully laminar, meaning that the ﬂow
patterns are completely predictable and turbulent mixing
does not occur. In some applications, such as microreactors,
which require mixing of diﬀerent reagents, this laminar ﬂow
pattern is an obstacle that has to be overcome. However,
the laminar nature of the ﬂuid ﬂow can also be used to
perform unique experiments that are diﬃcult or nearly
impossible to perform with conventional methods. Most of
these experiments rely on parallel ﬂuid ﬂows: if two streams
of ﬂuid enter the chip in a parallel fashion, the two streams
will remain separated and mixing of them will only occur
by diﬀusion. Thus, the degree of mixing can be tuned by
changing the ﬂow rate: the higher the ﬂow rate, the shorter
the residence time inside the device, the less the streams mix.
Therefore, as long as ﬂow rates are suﬃciently high, cells on
o n es i d eo ft h ed e v i c ec a nb et r e a t e dw i t ho n es u b s t a n c e ,
whereas cells on the other side are treated with another
substance. As a matter of fact, even two sides of a single cell
c a nb et r e a t e di nt h i sw a y[ 20].
Another important main feature of microﬂuidic technol-
ogy is that it is suitable for high-throughput, comprehensive
studies of cell biology. This means that the eﬀect of multiple
factorsandparametersoncellfunctioningcanbescreenedin
one assay. Increasing throughput is an active area of research
in the ﬁeld of microﬂuidics. Eﬀo r t sa r em a d et om e r g e
microﬂuidic technology with microarray and microtitre
plate technology [21–23]. Also, researchers are dedicated to
integrate multiple steps, such as cell culturing, lysis, and
analysis in one device. Numerous examples of this parallel
and serial microﬂuidic biochemical analysis, also known as4 Journal of Biomedicine and Biotechnology
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Figure 4: Endothelial cells in a microﬂuidic channel. (a) Human umbilical vein endothelial cells were cultured in a microﬂuidic channel.
When reaching conﬂuence, the cells were ﬁxated with paraformaldehyde and stained for actin ﬁlaments (green) and nuclei (blue). Scale
bar is 50μm. (b) Endothelial cells that are subjected to physiological levels of shear stress inside microﬂuidic channels reorient their actin
cytoskeleton to align with the direction of ﬂuid ﬂow (right). Scale bars are 50μm.
lab-on-a-chip, have already been reported and are starting to
be implemented in cell-containing microﬂuidic devices [16].
3.MicroﬂuidicTechnology andVascularCells
3.1. The Endothelial Mechanoresponse. Vascular endothelial
cells are highly responsive to shear stress that is caused by
the ﬂow of ﬂuid over their surface. This shear stress is the
result of the presence of a ﬂuid velocity gradient in the cross
section of a tube. The velocity of the ﬂuid next to the walls
is zero, whereas the velocity is maximal in the center of the
channel.Thesteeperthisgradient,thehighertheshearforces
that act on the vessel wall. The biological response to this
mechanical stimulus—the endothelial mechanoresponse—
has been found to be a key process in preventing vascular
disease[24].Themechanoresponseisusuallystudiedinvitro
by subjecting endothelial cells to shear stress in parallel plate
ﬂow chambers. Microﬂuidic devices can be considered as
miniaturized versions of these setups. Because shear stress is
proportional to ﬂow rate and inversely proportional to chan-
nel dimensions, only low ﬂow rates are needed in microﬂu-
idic channels to mimic the high shear stresses found in the
human body. Song et al. [25] took advantage of this fact by
designing a microﬂuidic device that can subject endothelial
cells to physiological levels of shear stress in multiple parallel
channels. They showed that a ﬂow rate of less than 200μL
per hour is already enough to make the sheared endothelial
cells elongate and orient in the direction of the ﬂow, which
is a prominent feature of the endothelial mechanoresponse
that is also found in vivo. This reorientation is also reﬂected
in the actin cytoskeleton of the cells. In our laboratory, we
subjected cells to a shear stress of 1Pa for 12 hours and
then stained the actin ﬁlaments with phalloidin-FITC. Most
ﬁlaments were aligned and oriented in the ﬂow direction
(Figure 4(b)). Recently, Tkachenko et al. [26] also reported
the design of a microﬂuidic device that allows for real-time
tracking of endothelial cells that are subjected to shear stress.
They could generate shear stresses ranging from 0.01 to 0.9
Painparallelchannels,usingﬂowratesintherangeofseveral
milliliters per hour. In contrast, ﬂow rates are in the order of
hundreds of milliliters per hour for the conventional, larger,
parallel plate ﬂow chambers. Because of the small volumes
of reagents that are needed, and the potential parallelized
design of microﬂuidic devices, they are an ideal platform
for screening of compounds that may have an impact on
the mechanoresponse. We have recently developed such
an assay, in which the morphological rearrangements of
endothelial cells are used to quantify the mechanoresponse.
Using this assay, the impact of inhibitory drugs on the
mechanoresponse can be detected (paper submitted).Journal of Biomedicine and Biotechnology 5
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Figure 5:Usesofparallelﬂuidﬂowsinsidemicroﬂuidicchannels.(a)Partsofthemicroﬂuidicchannelcanbetreateddiﬀerentlybypumping
two types of media into the two inlets. In this case, a ﬂuorescent label was added to one of the parallel ﬂuid streams. Flow is from bottom
to top; scale bar is 50μm. (b) When ﬂow rates are suﬃciently low, media reside in the channel long enough for diﬀusion to take place.
This phenomenon can be used to generate and maintain steady gradients in a channel. In this case, three parallel inlet streams were used,
containing 0μg/mL, 5μg/mL, and 10μg/mL dextran-rhodamine, respectively. When quantifying the ﬂuorescence over the width of the
channel, an almost linear gradient can be observed (white square box in the image, plotted in the inset). (c) By using parallel ﬂows, the
middle part of the channel was treated with trypsin. As a result, endothelial cells in the middle of the channel are selectively removed,
creating an artiﬁcial wound. The closing of this wound can be followed over time to quantify cell migration rates.
Another well-known eﬀect of applying shear stress to
endothelial cells is the release of the vasodilatant, nitric oxide
[27]. Microﬂuidic assays have already been reported that can
detect the production of nitric oxide in response to chemical
stimuli amperometrically [28] or by ﬂuorescence [29]. This
provides researchers with an interesting tool to study nitric
oxide release in response to both mechanical and chemical
stimuli.
When increasing the ﬂow rate and the resultant shear
stress, microﬂuidic devices can also be used to study the
adhesion strength of endothelial cells to their underlying
substrate. Young et al. [30]p e r f o r m e ds u c ha ne x p e r i m e n t
with endothelial cells of diﬀerent origins and two types of
matrix proteins. When the cells were subjected to a shear
stressthatisabouttentimeshigherthantypicalphysiological
values, a certain percentage of cells detached from the sur-
face.Inthismanner,itwaspossibletogiveasemiquantitative
indication of the strength of adhesion of diﬀerent cells on
diﬀerent substrates. These types of experiments used to
be performed with large, parallel plate shear devices that
consumed large amounts of media, cells, and reagents [31].
Downscaling of these setups to micrometer dimensions is a
clear advantage.
3.2. Migration Assays. As discussed earlier, multiple parallel
ﬂuid ﬂows can be introduced in one microﬂuidic channel.
Transport of components from one ﬂow to the other only
occurs by diﬀusion (Figure 5(a)). If ﬂow rates are low,
there is suﬃcient time for the parallel streams to exchange
components. If one of the streams contains a drug or
active compound, stable gradients can be generated by
taking advantage of this diﬀusion. An example of such a
gradient that was produced in our laboratory is shown in
Figure 5(b).Thereareanumberofstudiesthatshowhowthis
phenomenon can be used when experimenting with vascular
cells. Most of these studies focus on migration of vascular
cells in response to gradients of physical or biochemical cues.
Studying and understanding cell migration is important,
b e c a u s ei ti sap r o c e s si n v o l v e di ne m b r y o g e n e s i s ,w o u n d
healing, and tumorigenesis.6 Journal of Biomedicine and Biotechnology
Barkeforsetal.[32]studiedmigrationofendothelialcells
in gradients of vascular endothelial growth factor (VEGF).
They designed a device with three inlets, generating three
parallel ﬂuid streams in the main channel. When VEGF
was added to the middle stream, an increasing gradient
from the sides of the channel towards the middle was
generated. The steepness of this gradient could be tuned
by adjusting the ﬂow rates: the slower the ﬂow rate, the
longer the residence time in the channel, the more time there
is for VEGF to diﬀuse, and the more shallow the gradient
becomes. When endothelial cells were cultured in this stable
gradient of VEGF, they preferentially migrated towards the
middle of the channel. Because the researchers had control
over the shape of the gradient, they could show that steep
gradients induce faster migration. Moreover, it was found
that endothelial cells migrated fastest in gradients from 0
to 50ng/mL, whereas they were not able to sense gradients
from 50 to 100ng/mL due to saturation of the available
receptors.
Biochemical cues, such as the growth factors used in
this study, are not the only relevant stimuli for vascular cell
migration. In an elegant study, Zaari et al. [33] showed that
smooth muscle cells tend to migrate towards mechanically
stiﬀer underlying substrates. To reach this conclusion, the
authors designed a microﬂuidic device that could generate a
gradient of crosslinker, mixed with a solution of acrylamide.
A layer of gel with a gradient of stiﬀness was produced by
crosslinking the mixture withUVlightinto a polyacrylamide
network. When these gels were taken out of the microﬂuidic
devices and smooth muscle cells were seeded on them, all
cells tended to migrate towards the side of the gel with higher
stiﬀness.
Apart from migration assays that rely on gradients, the
parallel laminar ﬂuid streams can also be used to bring the
most conventional migration assay to a microﬂuidic scale.
This assay is the scratch assay or wound healing assay. It
works by growing cells in a monolayer, artiﬁcially creating
a scratch and then following how this scratch is closed by
directedmigration of thesurrounding cells.Inamicroﬂuidic
device, the artiﬁcial scratch can be generated by adding the
serine protease trypsin to one of the parallel ﬂuid streams.
W h e no n es i d eo ft h ec h a n n e lh a sb e e nc l e a r e do fc e l l sb y
trypsinization, the migration of the remaining cells can be
followedovertimetoquantifydirectedmigration.Sofar,this
assay has only been published with data on ﬁbroblasts [34],
but work in our group has shown that it is also possible with
endothelial cells (Figure 5(c)). The advantage of carrying out
this assay in a microﬂuidic device is that it can be more easily
combined with stimuli such as shear stress or growth factor
gradients.
3.3. Cell Interactions. The principle of parallel streams is
not just useful in studies of cell migration. It can also be
used to pattern cells inside a microﬂuidic device. This is
important when interactions between cells are the object of
study. Micrometer-scale patterning of cells can be achieved
by stamping adhesive proteins on a substrate [35]o r
by temporarily conﬁning cells in a microﬂuidic device
until they adhere, after which the device is removed from
the surface [36]. By using parallel streams, cells can be
patterned without the need of removing the microﬂuidic
device afterwards. When adding one cell type to one
stream and another type to the parallel stream, cells can
be cocultured in direct contact with each other inside
a microﬂuidic device [37]. For vascular research, this
method could be used to pattern endothelial cells and
smooth muscle cells in one device. The planar nature of
microﬂuidic devices would provide great opportunities for
studying interactions between these cell types. In literature,
there are numerous reports of microﬂuidic setups that
are used for vascular cell interaction studies. For example,
Song et al. [38] studied the interaction between endothe-
lial cells and circulating tumor cells, a process that is
important for cancer metastasis. They developed a device
in which a layer of endothelial cells can be stimulated
with chemokines from the bottom, while being treated
simultaneously with a suspension of breast cancer cells
from the top. When the endothelium was stimulated with
CXCL12, a chemokine implicated in metastasis, they found
that more cancer cells adhered to the layer of endothelial
cells than under basal conditions. Another study on metas-
tasis used a microﬂuidic chip with small, gel-coated gaps,
overlaid with a monolayer of endothelial cells to mimic
the basement membrane and the endothelium, respectively
[39]. Using this microﬂuidic in vitro model of a blood
vessel, tumor cell migration could be quantiﬁed and studied
in great detail with time-lapse microscopy. It is not just
interactions between tumor cells and endothelium that
are an interesting object of research in vascular science.
Studying the interactions between other circulating cells
and endothelial cells is also important. For example, the
binding of leukocytes to endothelial cells is an essential
step in inﬂammation [40], while the endothelium-mediated
activation of blood platelets is important in clotting and
thrombosis [41]. Multiple reports have been published by
groups that studied the adhesion of leukocytes [42]o r
platelets [43–45] to endothelial cells or endothelial cell-
derived adhesion factors in microﬂuidic devices. These
reportsshowthatmicroﬂuidiccellinteractionstudiesrequire
less sample and reagents than similar, conventional studies.
Moreover, a number of these studies already show increased
throughput by using parallel channels in one device [42, 44,
45].
3.4. Three-Dimensional Culturing. An important factor in
vascular cell physiology is its three-dimensional microen-
vironment. Cells are embedded in an environment that
comprises other cells, extracellular matrix proteins, bodily
ﬂuids, and blood. Three-dimensional cell culturing in the
laboratory can be performed by incorporating cells in a
hydrogel matrix (e.g., the commercially available, collagen-
based Matrigel), or by growing cells on top of this matrix,
allowing them to migrate into the gel [46]. Still, the
complex real-life, three-dimensional microenvironment is
usually reduced to a two-dimensional system when exper-
iments are carried out on cells in vitro. This is more
convenient, because with such a system cells can easily be
supplied with fresh growth medium, growth factors, andJournal of Biomedicine and Biotechnology 7
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Figure 6: Covering all surfaces of a microﬂuidic channel yields
“artiﬁcial capillaries.” Human endothelial cells were cultured in a
PDMS microﬂuidic channel and allowed to cover all surfaces. After
overnight culturing, cells were ﬁxated and actin ﬁlaments were
imaged with confocal laser scanning microscopy. Top image is a
pseudocolored top view of the microﬂuidic channel. The red line
marks the section that was used to construct a front view of the
channel (middle image). The bottom image is an isometric volume
view of the same channel.
other soluble compounds. Moreover, a two-dimensional
setup is more compatible with microscopy and imaging.
However, when using microﬂuidic devices, replenishment of
medium, generation of gradients, and microscopic imaging
is relatively easy to realize in a three-dimensional culturing
environment. A good example is the recent publication by
Vickerman et al. [47] They describe a microﬂuidic device
with two parallel channels, connected by a gel chamber.
The gel chamber is ﬁlled with a collagen-based hydrogel
and endothelial cells are grown in one of the channels.
By generating a gradient of soluble growth factors, the
endothelial cells grow into the gel and even form open
capillaries that span the entire gel chamber from channel
to channel. In this particular article, the gel is pipetted
into the gel chamber by microinjection before assembling
the device. However, using the laminar ﬂow properties
discussed earlier in this review, hydrogels can also be formed
in situ and even be patterned and conﬁned to certain
regions of the microﬂuidic device [48]. The great potential
of these three-dimensional culturing techniques was recently
underlined by Barkefors et al. [49], who cultured ex vivo
kidney tissue and followed the formation of blood vessels
in response to a VEGF gradient. Because of the small scale
of microﬂuidic devices, it is possible to advance this proof-
of-concept study towards high-throughput assays in order
to screen for compounds that aﬀect blood vessel formation
in such realistic models. A good example of this high-
throughputtrendistherecentstudybyHsiaoetal.[50],who
studied three-dimensional, spheroid cocultures of prostate
cancer cells and endothelial cells in a microﬂuidic device
with 28 side chambers that could all harbor a tumorous
spheroid.
3.5. Compound Screening Assays. In biomedical engineering,
a lot of research is dedicated to developing particle systems
that carry drugs, proteins, DNA for gene therapy or siRNA
for gene silencing to their proper site of action. In this
ﬁeld of research, it is important to have a way to quickly
screen for adhesion to endothelial cells—the ﬁrst barrier that
particles encounter when injected intravenously. Screening
under static conditions in well plates ignores the mechanical
forces caused by the ﬂowing blood, which counter particle
adhesion. A recent study by our group, using ﬂuorescent
siRNA-containingpolymerparticles,showsthatmicroﬂuidic
technology allows for quick screening of particle adhesion
to endothelial cells under dynamic conditions [51]. More
realistic microﬂuidic models of microvasculature have been
developed by Prabhakarpandian et al. [52] for the same
purposes. These devices contain channels that are designed
after real capillary networks. They show that capillary geom-
etry has a strong inﬂuence on local mechanical conditions
and particle adhesion. The fabrication of a more complex
microﬂuidic device that tries to mimic the tight blood-brain
barrier, while still being easy-to-use in high-throughput
assays, was recently reported by Genes et al. [53]. It is to
be expected that high-throughput screening in these more
realistic vascular models of the in vivo situation will become
the norm in drug development and material science in the
future.
3.6. Stem Cells and Tissue Engineering. Regenerative
medicine is the ﬁeld in which researchers try to engineer
tissues in the laboratory to replace damaged or missing
tissue in the human body. It is a multi disciplinary
ﬁeld, which combines materials science with cell biology
and biomedicine. A major challenge in this ﬁeld is the
production of vascularized tissue for implantation. In order
to achieve this, stem cells must be stimulated to diﬀerentiate
into vascular cells, and these vascular cells need to arrange
themselves into a vascular network. Microﬂuidic technology
can be of use in both processes. For diﬀerentiation of
human stem cells to vascular tissue, many factors can be
of inﬂuence. Because human stem cells and the inducing
factors are relatively diﬃcult to obtain, it is advantageous
to perform tests in a microﬂuidic setting instead of in a
macroscopic assay. Figallo et al. [54] developed a 12-well
micro-bioreactor in which human embryonic stem cells
were directed towards a vascular phenotype by varying
growth factors, perfusion, and cell seeding density. Using
such microﬂuidic devices instead of conventional techniques
saves reagents and allows for more ﬂexibility in terms of
culture parameters.8 Journal of Biomedicine and Biotechnology
The other aspect of vascular tissue engineering in which
microﬂuidic technology can be of help is in preparing
vascular networks that can be incorporated into tissue
constructs. This can be accomplished by two approaches.
First of all, a “synthetic capillary” can be engineered by
using microﬂuidic technology. This works by designing
a microﬂuidic channel of which the walls contain tiny
gaps of only a few micrometer in diameter and tens of
micrometers in length. Behind these gaps, compartments
are located in which tissue can be grown. When medium
is pumped through the channel, the gaps act as a simple
endothelium-like barrier, limiting mass transport to the
tissue compartments. An example of such a microﬂuidic
design was reported by Lee et al. [55], who used this
principle to design synthetic analogs of liver sinusoids. Using
this approach, mass transport over the endothelium-like
barrier can be tweaked to mimic the values found in human
vessels [56, 57]. A second approach to use microﬂuidic
technology for generation of vascular networks is based
on the notion that the microﬂuidic device itself can be
considered as a three-dimensional “scaﬀold” in which cells
can be grown. When all sides of a channel are completely
covered with endothelial cells, microvascular networks are
generated that mimic in vivo networks (Figure 6). It has
been shown that this approach will in principle work:
PDMS devices with microvascular network morphologies
can be completely covered with endothelial cells to generate
capillary-like structures [58]. However, PDMS is a non-
biodegradable polymer. Biodegradability is paramount if
eventually the material is to be replaced with functional
tissue. Another study has shown that the same type of
system can also be built with the biodegradable poly-
mer poly (glycerol sebacate) [59]. Still, these microﬂuidic
devices consist of only one ﬂat layer of vascular struc-
tures. A major challenge will be to build biodegradable,
truly three-dimensional microvascular networks that can
be combined with other materials and cells in regenerative
medicine. Novel rapid techniques for three-dimensional
devicefabrication,suchasstereolithographywithbiodegrad-
able polymers [60], hold great promise to overcome this
challenge.
4. Conclusion
The examples given in this review clearly illustrate the fact
that the use of microﬂuidic technology facilitates current
vascular research and, more importantly, opens up novel
areas of research that are not possible with more conven-
tional setups and techniques. It is important to realize not
only that microﬂuidic technology paves the way for more
realistic in vitro models in vascular cell biology but also that
the technology is still in its infancy in terms of throughput.
Almost all studies described in this review are proof-of-
principle experiments that require a lot of personal eﬀort
and intervention by the researcher. However, automation,
standardization, and increasing scale will all be natural
stages in the maturation of microﬂuidic technology. These
improvements will boost the systematic nature of vascular
cell biological research in the future.
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